Filing Details
- Accession Number:
- 0001161697-24-000256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-07 17:00:08
- Reporting Period:
- 2024-06-05
- Accepted Time:
- 2024-06-07 17:00:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1279473 | Gary Ingenito | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Chief Med. & Reg. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-06-05 | 80,000 | $4.01 | 131,391 | No | 4 | M | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2024-06-05 | 80,000 | $16.16 | 51,391 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase common stock | Disposition | 2024-06-05 | 80,000 | $0.00 | 80,000 | $4.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,050,575 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share.
- Options vested in three annual tranches beginning on January 2, 2019.